Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06392789

A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors

A Crossover Randomized Controlled Trial to Investigate the Acceptability and Efficacy of Cecebot, a Conversational Agent for Insomnia After Breast Cancer

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Washington · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates the effect of conversational agent, Cecebot, on improving insomnia in stage I-III breast cancer survivors. Sleep disturbance ranks among the top concerns reported by breast cancer survivors and is associated with poor quality of life. Many breast cancer survivors also have decreased physical activity, which may also have a negative impact on sleep and quality of life. Cognitive behavioral therapy for insomnia (CBTi) and physical activity interventions have individually been reported to improve sleep and to have a positive impact on quality of life. Cecebot is a personalized short messaging service (SMS)-based behavioral intervention that combines CBTi and physical activity strategies that may improve sleep for breast cancer survivors.

Detailed description

OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (INTERVENTION): Patients receive sleep education SMS conversations and access to website content modules over 10 minutes 2-4 times per week, sleep compression SMS conversations once weekly (QW), and wear activity tracker daily on weeks 1-6. GROUP II (WAITLIST CONTROL): Patients receive sleep education SMS conversations and access to website content modules over 10 minutes 2-4 times per week, sleep compression SMS conversations QW, and wear activity tracker daily on weeks 7-12.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavior Therapy for InsomniaReceive sleep education
OTHERInternet-Based InterventionReceive access to website content modules
OTHERMedical Device Usage and EvaluationWear activity tracker
OTHERQuestionnaire AdministrationAncillary studies
OTHERText Message-Based Navigation InterventionReceive sleep compression SMS conversations

Timeline

Start date
2024-10-04
Primary completion
2026-01-16
Completion
2026-05-31
First posted
2024-04-30
Last updated
2026-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06392789. Inclusion in this directory is not an endorsement.